These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25099136)

  • 1. Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation.
    Simsek-Kiper PO; Dikoglu E; Campos-Xavier B; Utine GE; Bonafe L; Unger S; Boduroglu K; Superti-Furga A
    Am J Med Genet A; 2014 Oct; 164A(10):2667-71. PubMed ID: 25099136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camurati-Engelmann disease--a rare cause of bone pain.
    Mundra V; Taxel P
    Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of pain and improvement of exercise capacity in Camurati-Engelmann disease with losartan.
    Ayyavoo A; Derraik JG; Cutfield WS; Hofman PL
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3978-82. PubMed ID: 25140400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.
    Cui L; Li Q; Guan W; Yu W; Li X; Xia W; Jiang Y
    Front Endocrinol (Lausanne); 2022; 13():882144. PubMed ID: 35784539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camurati-Engelmann Disease.
    Van Hul W; Boudin E; Vanhoenacker FM; Mortier G
    Calcif Tissue Int; 2019 May; 104(5):554-560. PubMed ID: 30721323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camurati-Engelmann Disease with Good Treatment Response to Losartan.
    Abdulla MC
    Indian J Nucl Med; 2019; 34(3):223-225. PubMed ID: 31293304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and treatment outcomes in Camurati-Engelmann disease: A case series.
    Kim YM; Kang E; Choi JH; Kim GH; Yoo HW; Lee BH
    Medicine (Baltimore); 2018 Apr; 97(14):e0309. PubMed ID: 29620655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro.
    McGowan NW; MacPherson H; Janssens K; Van Hul W; Frith JC; Fraser WD; Ralston SH; Helfrich MH
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3321-6. PubMed ID: 12843182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment responses in five patients with Ribbing disease including two with 466C>T missense mutations in TGFβ1.
    Savoie A; Gouin F; Maugars Y; Isidor B; Larrose C; Berthelot JM
    Joint Bone Spine; 2013 Dec; 80(6):638-44. PubMed ID: 23453470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new LRP6 variant and Camurati-Engelmann-like disease.
    Pickering ME; Ltaief-Boudrigua A; Feurer E; Collet C; Chapurlat R
    Bone; 2021 Feb; 143():115706. PubMed ID: 33164853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthopedic Manifestations of Type I Camurati-Engelmann Disease.
    Yuldashev AJ; Shin CH; Kim YS; Jang WY; Park MS; Chae JH; Yoo WJ; Choi IH; Kim OH; Cho TJ
    Clin Orthop Surg; 2017 Mar; 9(1):109-115. PubMed ID: 28261436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proband and the Brother.
    B S; Kotha JP
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease.
    Agarwal K; Rajan R; Paul J; Cherian KE; Kapoor N; Paul TV
    AACE Clin Case Rep; 2022; 8(2):54-57. PubMed ID: 35415233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease.
    Chen Y; Xie W; Hu F; Chen J; Zheng H; Zhou H; Ni B; Li W; Zhou J
    Mol Med Rep; 2017 Jan; 15(1):235-239. PubMed ID: 27959412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camurati-Engelmann disease: a case report from sub-Saharan Africa.
    Mwasamwaja AO; Mkwizu EW; Shao ER; Kalambo CF; Lyaruu I; Hamel BC
    Oxf Med Case Reports; 2018 Jul; 2018(7):omy036. PubMed ID: 30034812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 17-year-old adolescent with anorexia and gait abnormalities: Camurati-Engelmann syndrome.
    Meyer S; Gortner L; Varon R; Ziegler K; Kutschke G; Larsen A
    Acta Paediatr; 2012 Sep; 101(9):e387-8. PubMed ID: 22712665
    [No Abstract]   [Full Text] [Related]  

  • 17. Camurati-Engelmann Disease Complicated by Hypopituitarism: Management Challenges and Literature Review of Outcomes With Bisphosphonates.
    Das L; Dhiman V; Dutta P; Sood A; Prakash M; Kaur S; Steenackers E; Hendrickx G; Dayal D; Van Hul W; Bhadada SK
    AACE Clin Case Rep; 2022; 8(2):58-64. PubMed ID: 35415221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camurati-Engelmann disease: New clinical insights in an Egyptian case report.
    Wahba Y; Abdel Ghaffar NA; Shaltout A; Elsharkawy A
    J Orthop Sci; 2020 May; 25(3):529-532. PubMed ID: 28943142
    [No Abstract]   [Full Text] [Related]  

  • 19. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.
    Whyte MP; Totty WG; Novack DV; Zhang X; Wenkert D; Mumm S
    J Bone Miner Res; 2011 May; 26(5):920-33. PubMed ID: 21541994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Camurati-Engelmann disease].
    Kinoshita A
    Nihon Rinsho; 2015 Dec; 73(12):2149-59. PubMed ID: 26666167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.